Birchview Capital’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-245,127
| Closed | -$1.05M | – | 52 |
|
|
2023
Q2 | $1.05M | Hold |
245,127
| – | – | 0.79% | 22 |
|
|
2023
Q1 | $525K | Hold |
245,127
| – | – | 0.41% | 33 |
|
|
2022
Q4 | $485K | Hold |
245,127
| – | – | 0.34% | 35 |
|
|
2022
Q3 | $409K | Hold |
245,127
| – | – | 0.29% | 42 |
|
|
2022
Q2 | $680K | Hold |
245,127
| – | – | 0.49% | 29 |
|
|
2022
Q1 | $820K | Buy |
245,127
+186,667
| +319% | +$624K | 0.59% | 31 |
|
|
2021
Q4 | $360K | Hold |
58,460
| – | – | 0.23% | 50 |
|
|
2021
Q3 | $811K | Hold |
58,460
| – | – | 0.55% | 32 |
|
|
2021
Q2 | $1M | Hold |
58,460
| – | – | 0.6% | 30 |
|
|
2021
Q1 | $1.11M | Buy |
58,460
+3,333
| +6% | +$63K | 0.66% | 25 |
|
|
2020
Q4 | $1.6M | Hold |
55,127
| – | – | 0.92% | 19 |
|
|
2020
Q3 | $2.08M | Hold |
55,127
| – | – | 1.39% | 12 |
|
|
2020
Q2 | $1.84M | Buy |
55,127
+41,694
| +310% | +$1.39M | 1.11% | 13 |
|
|
2020
Q1 | $480K | Sell |
13,433
-20,607
| -61% | -$736K | 0.43% | 29 |
|
|
2019
Q4 | $1.5M | Buy |
34,040
+18,000
| +112% | +$794K | 1.09% | 11 |
|
|
2019
Q3 | $361K | Hold |
16,040
| – | – | 0.24% | 34 |
|
|
2019
Q2 | $674K | Hold |
16,040
| – | – | 0.41% | 26 |
|
|
2019
Q1 | $496K | Sell |
16,040
-27,733
| -63% | -$858K | 0.31% | 30 |
|
|
2018
Q4 | $1.12M | Hold |
43,773
| – | – | 1.06% | 10 |
|
|
2018
Q3 | $1.42M | Sell |
43,773
-1,456
| -3% | -$47.2K | 0.92% | 11 |
|
|
2018
Q2 | $1.59M | Hold |
45,229
| – | – | 1.08% | 12 |
|
|
2018
Q1 | $1.23M | Hold |
45,229
| – | – | 0.81% | 13 |
|
|
2017
Q4 | $1.03M | Buy |
+45,229
| New | +$1.03M | 0.6% | 14 |
|